Amgen VP Encouraged By Initial Clinical Trial Diversity Efforts
Progress Also Made In Diversifying Management
Ponda Motsepe-Ditshego, who leads Amgen’s clinical trial diversity efforts, admits they are in early stages but noted progress internally and externally at better representing diverse patient groups.